Our Team

Entrepreneurial and intuitive, Miriam founded mdgroup in 2002. Today mdgroup is a digital and patient health services business offering a range of personalised services to support clinical trials on a global scale.

As Executive Chair of our board, Miriam uses her extensive industry experience to inspire a culture of ‘putting patients first’ – ensuring patients’ needs are top of mind in everything the team does.

Miriam’s success is reflected in her desire to help others achieve the same. As Chair of Women in Business European Council for WEConnect Europe, she tirelessly champions women-led enterprise, education and networking. Through our charity and as a trustee of the MD Educational Foundation, Miriam shares her own personal journey from finding her way as a school-leaver to establishing her own successful business, where she mentors and strives to inspire this entrepreneurial spirit.

As CEO, Tarquin is a creative, solutions-focused and pioneering leader. He takes an entrepreneurial and dynamic approach to extending the reach of our business and is passionate about what can be gained through challenging the status quo.

Tarquin creates, implements and enshrines both our strategic plans and our cultural values across the business. He ensures mdgroup is at the cutting edge of clinical services development, delivering our industry-leading services around the world.

Tarquin’s expertise builds on a career in global senior management across the biopharmaceutical and clinical services sector. For him, respect for the patients’ voice and needs lies at the heart of a successful clinical trial. Tarquin loves the human interaction of people and technology, which he believes makes the clinical trial experience more personal and accessible for patients and healthcare practitioners alike.

Jean brings a valuable external focus and independent scrutiny to the mdgroup board. She influences our strategic direction and drives innovation by contributing fresh ideas for service opportunities that expand our reach.

As Non-executive Director, Jean is motivated by the chance to help grow an organisation that is focused on the patient, making a difference in clinical research practices and helping pharma to develop new treatments. Skilled in assimilating and summarising information to distil key findings and points, she offers intelligent questions and constructive feedback.

Jean’s value stems, in part, from her previous extensive experience in the pharmaceutical industry where she held senior roles in clinical development and outsourcing/procurement, spanning areas ranging from travel and facilities management to marketing and sales.

Specialising in CFO and Non-Exec Director support for IT, tech, and service businesses, Steve brings over 20 years of experience working for UK businesses and International Groups to mdgroup.

Since qualifying as an ACA with Deloitte, Steve has enjoyed a successful career working across a range of sectors and complex businesses from SMEs to FTSE 250 – managing their growth both organically and through acquisitions. In recent years, Steve has had a particular focus in the Life Sciences sector.

In his current role, Steve provides support and guidance to the mdgroup board, bringing challenge and oversight in the areas of finance and international operations.

Ian sits on our board as Non-Executive Director, bringing valuable insights from mdgroup’s customer base alongside an independent scrutiny of our company strategy. By influencing the strategic direction, Ian supports the executive team to prioritise ideas and drive innovation based on market needs.

Ian brings a wealth of experience to his role, having grown a health technology business focused on high-quality service to patients and clients. He is skilled in identifying new opportunities to bring services and technology together in underserved markets.

Ian’s value is derived, in part, from extensive development experience and building long-standing relationships with the mdgroup business as a customer. This affords him a unique perspective from which to think creatively about our products and services.

David is a Development Operations expert with extensive global experience across a wide range of therapeutic areas. His career spans working with some of the largest pharmaceutical and biotech companies, as well as contract research organisations and start-up biotech and service companies.

David has a proven track record of leading operations through key transitions, from research into development and through to the completion of the product lifecycle. He has successfully built and led teams through IND, CTA, BLA, and NDA filings, as well as post-marketing line extensions, ensuring seamless execution and regulatory compliance.

With his depth of expertise and experience across diverse organisational settings, David brings exceptional insight and leadership to every stage of drug development.

He has a proven track record of leading global teams within sponsor organisations and contract research organisations (CROs).

Recognised as a PharmaVoice Top 100 leader, Peter is renowned for fostering highly effective collaborations between sponsors, CROs, investigator sites, and patient advocacy groups. His commitment to advancing research is further demonstrated through his roles on councils and advisory boards supporting Parkinson’s disease research and policy initiatives.

Based in Paris since 2019, Peter brings a wealth of international expertise to the teams he leads, enhancing global perspectives and operational excellence.

As the Deputy to our Chief Operating Officer, and head of our North America territory, LaQuinta brings a wealth of healthcare knowledge and expertise in building sustainable, strong commercial relationships.

By listening carefully to each client’s challenges, concerns and goals, LaQuinta works with them to find effective solutions. With a life sciences career spanning operations and sales, she has a balanced perspective: she knows what it takes to bring a product to market on time, retain patients and do so within budget, while putting the patient at the heart of what we do.

Enthusiastic and energetic, LaQuinta is motivated by a desire to improve the patient experience by removing any challenge that could impact their quality of life during a clinical trial. For her, being part of mdgroup is about more than selling a service: it’s about focusing on lasting and productive partnerships that always put the patient first.

Rebecca brings over 23 years of expertise in clinical trials operations within the pharmaceutical and clinical research sectors. Most recently, she served as Executive Director and Head of Global Clinical Operations at Allucent, where she led a large, multi-regional department spanning North America, Europe, the Middle East, and Asia Pacific. Her proven ability to establish innovative processes has significantly enhanced patient-centric approaches, notably during her tenure at Vault Health, where she developed decentralised clinical trial processes prioritising the patient experience.

Rebecca holds a Master’s in Biomedical Sciences from King’s College London and a Bachelor’s in Biomedical Sciences from the University of Wales, Cardiff. Her wealth of experience and unwavering commitment to patient care make her an invaluable addition to our mdgroup executive team.

Chris Prantl is a meticulous data privacy and compliance professional committed to delivering strategic, pragmatic solutions that ensure adherence to legal and regulatory obligations. With a focus on developing and implementing streamlined control frameworks, Chris optimises performance, minimises risk, and ensures compliance by promoting consistent, effective, and efficient practices.

Drawing on substantial expertise in data privacy, compliance, risk mitigation, and business transformation, Chris excels at navigating complex regulatory landscapes. His skillset encompasses project management, sales process design, and business process re-engineering, enabling him to create bespoke solutions tailored to organisational needs.

With hands-on experience spanning over 100 countries and a proven track record across a range of industries, Chris brings a unique, global perspective to data protection challenges at mdgroup.

As a regional leader, Leah thrives on working collaboratively with clients to enable them each to achieve their specific goals. Innovative and determined, she shapes ideas, concepts and approaches to fit their individual requirements, gaining satisfaction from playing her part in empowering others to do well.

Leah’s strengths lie in her organisational and development abilities. She focuses on supporting each person as an individual and making the team more effective as a whole. She isn’t happy until the client is and will work tirelessly to achieve that goal.

A process-driven and inclusive leader, Leah brings her expertise in account management and delivery across the medical communications and clinical research sectors to her current role.

Ian came to his position as Financial Director with a wealth of experience. He qualified as a Fellow Member of the Association of Chartered Certified Accountants in practice and has held senior financial roles in FTSE 100 companies around the world including GSK, Vodafone and K3 business technologies, a key partner for Microsoft.

Having been involved in large scale company growth during his career, Ian has implemented various accounting systems on a global level, reporting to financial compliance bodies where he has worked in the UK, North America and Europe.

Ian drives our corporate performance and profitability, maintaining the highest quality reporting across our global enterprise. He’s passionate about the mdgroup commitment to delivering remarkable results for our clients and takes a dynamic, strategic approach to mdgroup product development and innovation, keeping us at the forefront of the clinical research industry.